Dandelion leaf extract protects against liver injury induced by methionine- and choline-deficient diet in mice

Journal of Medicinal Food

Volumn 16, Issue 1, 2013, Pages 26-33

  Davaatseren, Munkhtugs ^a,b   Hur, Haeng Jeon ^a   Yang, Hye Jeong ^a   Hwang, Jin Taek ^a   Park, Jae Ho ^a   Kim, Hyun Jin ^a   Kim, Myung Sunny ^a   Kim, Min Jung ^a   Kwon, Dae Young ^a   Sung, Mi Jeong ^a  

^a Korea Food Research Institute   (South Korea)

^b University of Science and Technology (UST)   (South Korea)

Author keywords

fatty liver; hepatotoxicity; inflammation; oxidative stress; Taraxacum officinale

Indexed keywords

ALANINE AMINOTRANSFERASE; CASPASE 3; CHOLINE; DANDELION LEAF EXTRACT; GLUTATHIONE; INTERLEUKIN 6; MALONALDEHYDE; METHIONINE; PLANT EXTRACT; PROCASPASE 3; STRESS ACTIVATED PROTEIN KINASE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DANDELION; DISEASE SEVERITY; LIVER HISTOLOGY; LIVER PROTECTION; MOUSE; NONALCOHOLIC FATTY LIVER; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT; WESTERN BLOTTING;

ANIMALS; CHOLINE; CHOLINE DEFICIENCY; FATTY LIVER; HUMANS; INTERLEUKIN-6; LIVER; MALE; METHIONINE; MICE; MICE, INBRED C57BL; PLANT EXTRACTS; PLANT LEAVES; PROTECTIVE AGENTS; TARAXACUM; TUMOR NECROSIS FACTOR-ALPHA;

MURINAE; MUS; TARAXACUM OFFICINALE;

EID: 84872121544     PISSN: 1096620X     EISSN: 15577600     Source Type: Journal    
DOI: 10.1089/jmf.2012.2226     Document Type: Article

References (36)

1. Day CP, James OF: Steatohepatitis: a tale of two ''hits''? Gas-troenterology 1998;114:842-845.
2. Chan NN, Kong AP, Chan JC: Metabolic syndrome and type 2 diabetes: the Hong Kong perspective. Clin Biochem Rev 2005;26:51-57.
3. Lai SW, Tan CK, Ng KC: Epidemiology of fatty liver in a hospital-based study in Taiwan. South Med J 2002;95:1288-1292.
4. Farrell GC, Larter CZ: Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 2006;43:S99-S112.
5. Aghazadeh S, Yazdanparast R: Inhibition of JNK along with activation of ERK1/2 MAPK pathways improve steatohepatitis among the rats. Clin Nutr 2010;29:381-385.
6. Koh YJ, Cha DS, Ko JS, Park HJ, Choi HD: Anti-inflammatory effect of Taraxacum officinale leaves on lipopolysaccharide-induced inflammatory responses in RAW 264.7 cells. J Med Food 2010;13:870-878.
7. Rácz-Kotilla E, Rácz G, Solomon A: The action of Taraxacum officinale extracts on the body weight and diuresis of laboratory animals. Planta Med 1974;26:212-217.
8. Schutz K, Kammerer DR, Carle R, Schieber A: Characterization of phenolic acids and flavonoids in dandelion (Taraxacum offi-cinale WEB. ex WIGG.) root and herb by high-performance liquid chromatography/electrospray ionization mass spectrome-try. Rapid Commun Mass Spectrom 2005;19:179-186. (Pubitemid 40175468)
9. Schütz K, Carle R, Schieber A: Taraxacum\-a review on its phytochemical and pharmacological profile. J Ethnopharmacol 2006;107:313-323. (Pubitemid 44344437)
10. Park CM, Cha YS, Youn HJ, Cho CW, Song YS: Amelioration of oxidative stress by dandelion extract through CYP2E1 suppres-sion against acute liver injury induced by carbon tetrachloride in Sprague-Dawley rats. Phytother Res 2010;24:1347-1353.
11. Domitrović R, Jakovac H, Romić Z, Rahelić D, Tadić Z: Antifibrotic activity of Taraxacum officinale root in carbon tetrachloride-induced liver damage in mice. J Ethnopharmacol 2010;130:569-577.
12. You Y, Yoo S, Yoon HG, Park J, Lee YH, Kim S, Oh KT, Lee J, Cho HY, Jun W: In vitro and in vivo hepatoprotective effects of the aqueous extract from Taraxacum officinale (dandelion) root against alcohol-induced oxidative stress. Food Chem Toxicol 2010;48:1632-1637.
13. Park CM, Park JY, Nor KH, Shin JH, Song YS: Taraxacum officinale Weber extracts inhibit LPS-induced oxidative stress and nitric oxide production via the NF-?B modulation in RAW 264.7 cells. J Ethnopharmacol 2011;133:834-842.
14. Park CM, Youn HJ, Chang HK, Song YS: TOP1 and 2, poly-saccharides from Taraxacum officinale, attenuate CCl(4)-induced hepatic damage through the modulation of NF-kappaB and its regulatory mediators. Food Chem Toxicol 2010;48:1255-1261.
15. Yu J, Ip E, Dela PA, Hou JY, Sesha J, Holl P, Kisch R, Leclercp I, Farrell GC: COX-2 induction in mice with experimental nu-tritional steatohepatitis: role as pro-inflammatory mediator. He-patology 2006;43:826-836.
16. Draper HH, Hadley M: Malondialdehyde determination as index of lipid peroxidation. Methods Enzymol 1990;186:421-431. (Pubitemid 20279983)
17. Sung MJ, Kim DH, Jung YJ, Kang KP, Lee AS, Lee S, Kim W, Davaatseren M, Hwang JT, Kim HJ, Kim MS, Kwon DY, Park SK: Genistein protects the kidney from cisplatin-induced injury. Kidney Int 2009;74:1538-1547.
18. Rizki G, Arnaboldi L, Gabrielli B, Yan J, Lee GS, Ng RK, Turner SM, Dadger TM, Pitas RE, Maher JJ: Mice fed a lipo-genic methionine-choline- deficient diet develop hypermetabo-lism coincident with hepatic suppression of SCD-1. J Lipid Res 2006;47:2280-2290. (Pubitemid 44936138)
19. Zwart D, Meerman JH, Commandeur JN, Vermeulen NP: Bio-markers of free radical damage applications in experimental animals and in humans. Free Radic Biol Med 1999;26:202-226. (Pubitemid 29001507)
20. Ura S, Masuyama N, Graves JD, Gotoh Y: MST1-JNK promotes apoptosis via caspase-dependent and independent pathways. Genes Cells 2001;6:519-530. (Pubitemid 32655384)
21. George J, Pera N, Phung N, Leclercq IA, Hou JY, Farrell GC: Lipid peroxidation, stellate cell activation and hepatic fibrogen-esis in a rat model of chronic steatohepatitis. J Hepatol 2003; 39:756-764. (Pubitemid 37372185)
22. Haque JA, McMahan RS, Campbell JS, Shimizu-Albergine M, Wilson AM, Botta D, Bammler TK, Beyer RP, Montine TJ, Yeh MM, Kavanagh TJ, Fausto N: Attenuated progression of diet-induced steatohepatitis in glutathione-deficient mice. Lab Invest 2010;90:1704-1717.
23. Aghazadeh S, Amini R, Yazdanparast R, Ghaffari SH: Anti-apoptotic and anti-inflammatory effects of Silybum marianum in treatment of experimental steatohepatitis. Exp Toxicol Pathol 2011;63:569-574.
24. Harris GK, Qian Y, Leonard SS, Sbarra D, Shi X: Luteolin and chrysin differentially inhibit cyclooxygenase-2 expression and scavenge reactiveoxy-gen species but similarly inhibit prostaglan-din-E2 formation in RAW264.7 cells. JNutr 2006;136:1517-1521. (Pubitemid 43765355)
25. Hu C, Kitts DD: Antioxidant, prooxidant, and cytotoxic activities of solvent- fractionated dandelion (Taraxacum officinale) flower extracts in vitro. JAgric Food Chem 2003;51:301-310.
26. Ribeiro PS, Cortez-Pinto H, Sola S, Castro RE, Ramalho RM, Baptista A, Moura MC, Rodriques CM: Hepatocyte apoptosis, expression of death receptors, and activation of NF-kappaB in the liver of nonalcoholic and alcoholic steatohepatitis patients. Am J Gastroenterol 2004;99:1708-1717. (Pubitemid 39237497)
27. Feldstein AE, Canbay A, Angulo P, Taniai M, Burgart LJ, Lindor KD, Gores GJ: Hepatocyte apoptosis and Fas expression are prominent features of human nonalcoholic steatohepatitis. Gas-troenterology 2003;125:437-443. (Pubitemid 36929425)
28. Tilg H, Diehl AM: Cytokines in alcoholic and nonalcoholic steatohepatitis. N Engl J Med 2000;343:1467-1476.
29. Nan Y, Wang R, Zhao S, Han F, Wu WJ, Kong L, Fu N, Wu WJ: Heme oxygenase-1 prevents non-alcoholic steatohepatitis through suppressing hepatocyte apoptosis in mice. Lipids Health Dis 2010;9:124-133.
30. Yu J, Chu ES, Wang R, Wang S, Wu CW, Wong VW, Chan HL, Farrell GC, Sung JJ: Heme oxygenase-1 protects against steato-hepatitis in both cultured hepatocytes and mice. Gastro-enterology 2010;138:694-704.
31. Koteish A, Mae Diehl A: Animal models of steatohepatitis. Best Pract Res Clin Gastroenterol 2002;16:679-690.
32. Klover PJ, Zimmers TA, Koniaris LG, Mooney RA: Chronic exposure to interleukin-6 causes hepatic insulin resistance in mice. Diabetes 2003;52:2784-2789. (Pubitemid 37339708)
33. Ramadori G, Christ B: Cytokines and the hepatic acute-phase response. Semin Liver Dis 1999;19:141-155.
34. Hirosumi J, Tuncman G, Chang L, Görgün CZ, Uysal KT, Maeda K, Karin M, Hotamisligil GS: A central role for JNK in obesity and insulin resistance. Nature 2001;420:333-336.
35. Shen B, Yu J, Wang S, Chu ES, Wong VW, Zhou X, Lin G, Sung JJ, Chan HL: Phyllanthus urinaria ameliorates the severity of nutritional steatohepatitis both in vitro and in vivo. Hepatology 2008;47:473-483. (Pubitemid 351280715)
36. Weston CR, Davis RJ: The JNK signal transduction pathway. Curr Opin Cell Biol 2007;19:142-149. (Pubitemid 46386399)